XXI Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.4M Buy
3,607
+682
+23% +$272K 0.56% 40
2026
Q2
$1.13M Sell
2,925
-17
-0.6% -$6.3K 0.52% 41
2026
Q1
$861K Sell
2,942
-445
-13% -$146K 0.49% 54
2025
Q4
$1.19M Buy
+3,387
New +$1.14M 0.72% 31

Other funds holding ELV

XXI Wealth's ELV Position: Q3 2026 in Review

XXI Wealth increased its Elevance Health (ELV) stake by 23% in Q3 2026, buying an estimated $272K and bringing the position to 3,607 shares worth $1.4M. The position accounts for 0.56% of the portfolio, ranked #40.

XXI Wealth first reported a position in ELV in Q4 2025 and has held it in 4 quarters since. 1,411 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • XXI Wealth held 3,607 shares of Elevance Health worth $1.4M as of Q3 2026.
  • XXI Wealth bought 682 Elevance Health shares in Q3 2026, an estimated $272K.
  • Elevance Health made up 0.56% of XXI Wealth's portfolio in Q3 2026, its #40 holding.
  • XXI Wealth first reported a position in Elevance Health in Q4 2025 and has held it in 4 quarters since.
  • 1,411 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.